We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI Algorithm Non-Invasively Measures Intracranial Pressure in ICU Patients Following Traumatic Brain Injury

By HospiMedica International staff writers
Posted on 24 Jul 2024

Intracranial pressure (ICP) is a critical physiological parameter that may increase dangerously due to conditions like acute brain injury, stroke, or obstructions in cerebrospinal fluid flow. More...

Symptoms of high ICP include headaches, blurred vision, vomiting, behavioral changes, and a reduced level of consciousness, posing serious health risks. Traditional ICP monitoring methods are highly invasive, involving the insertion of devices such as external ventricular drains (EVD) or intraparenchymal brain monitors (IPM) directly into the brain through the skull. These methods, while effective, carry significant risks including catheter misplacement, infection, and hemorrhaging, occurring in approximately 15.3%, 5.8%, and 12.1% of cases respectively. Additionally, they require surgical expertise and specialized equipment not always available in many medical settings, highlighting the need for less invasive monitoring techniques.

Now, researchers at Johns Hopkins University School of Medicine (Baltimore, MD, USA) have proposed a novel, less invasive method for monitoring ICP. Published in the July 12 journal of Computers in Biology and Medicine, their research explores the correlation between ICP waveforms and three commonly measured physiological signals in the ICU: invasive arterial blood pressure (ABP), photoplethysmography (PPG), and electrocardiography (ECG). By employing these data points, researchers trained various deep learning algorithms, achieving a predictive accuracy for ICP that is comparable or superior to existing methods. This research indicates the possibility of a new, noninvasive technique for ICP monitoring, potentially transforming patient care in critical settings.

“ICP is universally accepted as a critical vital sign - there is an imperative need to measure and treat ICP in patients with serious neurological disorders, yet the current standard for ICP measurement is invasive, risky, and resource-intensive,” said researcher Robert Stevens, MD., MBA. “Here we explored a novel approach leveraging Artificial Intelligence which we believed could represent a viable noninvasive alternative ICP assessment method.”

Related Links:
Johns Hopkins University School of Medicine


Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Radial Artery Compression Device
TR Band
New
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: For the first time, a fluorescent-guided nerve imaging agent has shown promise for use in humans (Photo courtesy of VUMC)

Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.